Clinical Research Of Stable Angina Pectoris Of Coronary Heart Disease With Syndrome Of Intermingled Phlegm And Blood Stasis

Purpose: This study will utilize method of dissipate phlegm and dredge collaterals totreat coronary heart disease. Consequently to evaluate experienced prescriptionsYZKXY(YZKXY) of professor Huang Yongsheng in the clinical efficacy and safety and thento make accurate objective evaluation.Method: This research selects60cases of coronary heart disease patients with stableangina with syndrome of intermingled phlegm and blood stasis and divides into two groups(test team and matched group) at random. Each group consists of30patients. Test team takeYZKXY,150ml,bid;matched group take dan lou pian,5tablet,tid.It takes4weeks for oneperiod of treatment.Result:The statistical analysis shows that YZKXY to disease and angina pectoris integraleffect on patients are better than control group, syndromes integral treatment of patients areobviously improved, and better than control group, and in improving serum lipids has obviouseffect. ECG effect has no obvious difference between two groups. Adverse reactions don’thappen in clinical observation process and all safety testing index don’t abnormally change.Conclusion: Through the YZKXY clinical observation of the treatment of coronary heartdisease and angina with syndrome of intermingled phlegm and blood stasis,it has a specificcurative effect in the treatment of coronary heart disease stable angina with the YZKXY. Itcuts down obviously TC, TG, LDL-C level and prevent the further progression of coronaryheart disease. But YZKXY are the same in ECG improvement with dan lou pian group. Tosum up, YZKXY is the treatment of coronary heart disease angina in clinical research.Because it hasn’t any adverse reactions, it will bring more benefit for patients.